Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002110:Caffeine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003913:Dextroamphetamine / Q000627:therapeutic use; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D007099:Imipramine / Q000627:therapeutic use; D008774:Methylphenidate / Q000627:therapeutic use
D008774:Methylphenidate; D002110:Caffeine; D007099:Imipramine; D003913:Dextroamphetamine